- SPACs
- Deep Medicine Acquisition Corp.
Deep Medicine Acquisition Corp.
Completed 2024-02-06- CIK 1857086
- DMAQ
- IPO 2021-10-28
- $6.7M trust
- 240 filings
Successfully merged with TruGolf, Inc.
- IPO Size
- $127M
- raised at the IPO
- Trust
- $6.7M
- as of 2023-12-31
- Current Status
- Completed
- from its latest filing
- IPO Year
- 2021
- year it listed
Filings, by quarter
240 filings over 22 quarters; violet bars carry a milestone
- 21 Q3: 4 filings
- 21 Q4: 28 filings
- 22 Q1: 7 filings
- 22 Q2: 5 filings
- 22 Q3: 10 filings
- 22 Q4: 12 filings
- 23 Q1: 8 filings
- 23 Q2: 7 filings
- 23 Q3: 13 filings
- 23 Q4: 26 filings
- 24 Q1: 21 filings
- 24 Q2: 4 filings
- 24 Q3: 13 filings
- 24 Q4: 7 filings
- 25 Q1: 4 filings
- 25 Q2: 17 filings
- 25 Q3: 16 filings
- 25 Q4: 4 filings
- 26 Q1: 12 filings
- 26 Q2: 7 filings
- 26 Q3: 8 filings
- 26 Q4: 7 filings
- S-1 filed 21 Q3
- IPO 21 Q4
- Definitive agreement 23 Q1
- Completed 24 Q1
SPAC Overview
Where it stands on the road from S-1 to merger
Timeline Progress
- Registration2021-08-03 Filed S1
- IPO2021-10-28 IPO, search begins
- Definitive Agreement2023-03-31 Agreement for merger
- Completed2024-02-06 Merger Completed
About
Deep Medicine Acquisition Corp. is a blank-check company seeking an initial business combination, with a stated focus on healthcare targets valued at approximately $300 million to $1 billion.
Investment Focus
Healthcare
Key Information
As the filings state it
- IPO Date
- 2021-10-28
- Total Redemptions
- $128M
- PIPE
- $11M
- Jurisdiction of Incorporation
- Delaware
- SIC
- 6770
- Completion Date
- 2024-02-06
- Merger Target
- TruGolf, Inc.
- SPAC Ticker
- DMAQ
SPAC Team
The banks on its IPO, and the team as the filings describe it
Underwriters
Extended Team Information
The management team brings healthcare and medical AI, biotechnology investment, technology, finance, asset management and capital investment experience.